FDA WARNING: TOPAMAX SIGNIFICANTLY INCREASES THE RISK OF BIRTH DEFECTS IN PREGNANT USERS

March 20th, 2011

FDA Warning-Topiramate High Risk Birth DefectsTopiramate (brand name Topamax) an anti-seizure prescription drug that is also used for migraine prevention, has been found to significantly increase the risk of birth defects when used by pregnant women.

Infants who were exposed to Topamax while in the womb had a 1.4% prevalence of oral clefts (cleft palates) compared to just .38-.55% with other antiepileptic drugs.

Dr. Russell Katz of the FDA states“Before topirmate is prescribed, health care professionals should warn patients of childbearing age about the potential hazard to the fetus if a woman becomes pregnant while taking this drug.”  “Alternative medications that have a lower risk of birth defect should be considered.”

For those women of child-bearing age, who are also suffering with chronic migraine headaches, and don’t want to expose themselves to this risk,  MigreLief   the well-known, safe and very effective nutritional medicine for migraine relief, is a great alternative.

More Common and Serious Side Effects of Topamax